Thalidomide/Dexamethasone vs MP for Induction Therapy and Thalidomide/Intron A vs Intron A for Maintenance Therapy

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2001
This is an international multi-center prospective, double randomized, open, controlled phase III study with a phase II entrance phase to compare the therapeutic efficacy of thalidomide plus dexamethasone to conventional melphalan plus prednisone in newly diagnosed myeloma patients.
Epistemonikos ID: 70d2ca22cc904c1ef1aecbcb21f64c8100690fd9
First added on: May 04, 2024